Several recent studies have pointed out the importance of group B streptococci as human pathogens (2, 3, 12, 16, 23) . Because streptococci of groups A, B, and D differ in their susceptibility to antibiotics, including penicillin, reliable methods are needed for differentiating these streptococci from one another and from other streptococci (14, 18, 21) . Many laboratories that do not perform sero-grouping of streptococci rely on presumptive tests, such as bacitracin susceptibility for group A streptococci, to identify the pathogenic streptococci. Two presumptive tests for group B streptococci have been proposed. The CAMP reaction is based on an enhancement of the hemolytic action of group B streptococci in the presence of beta-hemolytic staphylococci (7) . Hydrolysis of sodium hippurate by group B streptococci was described by Ayers and Rupp (1) . Braunstein et al. (4) made use of hippurate hydrolysis to identify group B streptococci, but they did not mention the fact that some group D streptococci can hydrolyze sodium hippurate (5, 19) . This report describes how sodium hippurate hydrolysis can be used to presumptively identify beta-hemolytic group B streptococci. It also contains information on non-serological identification of group A (bacitracin susceptibility), group D (bile-esculin reaction), and enterococcal streptococci (bile-esculin and salt tolerance). MATERIALS Methods for determining hemolytic and catalase activity, serological grouping, and Gram staining have been previously described (11) . Serological grouping and determination of hemolytic activity were performed on all streptococci used in this study. Determination of catalase activity and Gram stains were performed on all group D, alpha-hemolytic non-group D (viridans), and beta-hemolytic non-groupable streptococci.
Commercial bacitracin disks were purchased from Bioquest (Taxo A disks). Neopeptone infusion agar (Difco) blood plates (4% rabbit blood) were prepared. The blood agar plates were marked into quarters, and each quarter was streaked with a loop (3 mm) of an overnight broth culture. A bacitracin disk was placed in the upper third (heaviest part) of the inoculum. The plates were inverted and incubated aerobically at 35 C for 24 h. Plates were considered positive when there was a zone of inhibition and negative where there was growth up to the disk, or no inhibition.
Broth for determining hippurate hydrolysis was prepared by adding 10 g of sodium hippurate to 1 liter of heart infusion broth (Difco). The The procedures for preparing and reading the following tests have been previously described (10, 11) : bile-esculin and modified bile-esculin, 6 .5% NaCl (salt broth) and modified 6.5% NaCl (modified salt broth), and Streptococcus faecalis (SF) broth. Unmodified bile-esculin medium (BEM) and salt broth were used from July 1967 to July 1971, and modified bile-esculin and modified salt broth were used during the latter part of this study.
A battery of physiological tests (9) was used to identify the group D and other alpha-hemolytic streptococci. In a separate study in which silica gel-transported swabs were used, the presumptive test reactions of beta-hemolytic streptococci were determined before the sero-grouping results were known. Nose, throat, vaginal, and umbilical swabs were placed in 5 ml of Todd-Hewitt broth (THB, Difco) and incubated for 24 h at 35 C. Pour plates were made by transferring one loop of the overnight THB culture to 15 ml of sterile physiological saline in a 40-ml centrifuge tube. The loop was sterilized, and one loop of the salinediluted organisms was placed in 15 ml of melted neopoptone infusion agar in a 40-ml centrifuge tube. A 0.6-ml portion of defibrinated rabbit blood was then added to the melted agar. The inoculum, blood, and melted agar were mixed thoroughly and poured into a plastic petri dish (15 by 100 mm). Plates were incubated overnight at 35 C. Hemolysis was read with a broad-field microscope according to the method of Brown (6) . Beta-hemolytic colonies were "fished" from the pour plate into 30 ml of THB in 40-ml centrifuge tubes. The 30 ml of THB was incubated overnight at 35 C. Inocula for bacitracin susceptibility, sodium hippurate hydrolysis, bile-esculin reaction, and 6.5% NaCl broth tests were taken from the 30-ml THB before extraction. Bacitracin susceptibility, bile-esculin reaction, and salt tolerance tests were read after 24 serogroups C, F, G, L, M, and non-groupable.
The "group D enterococci" category consists of S. faecalis and its varieties zymogenes and liquefaciens, S. faecium, and S. durans (9) . The "group D non-enterococci" category is made up of S. bovis and S. equinus. The "viridans" streptococci are made up of alpha-and nonhemolytic streptococci whose extracts failed to react with CDC group A, B, C, D, and G antisera, or reacted with one of the CDC group F, H, K, or 0 antisera. No beta-hemolytic group H, K, or 0 streptococci were identified during the period of this study. Several alphahemolytic streptococcal species are known to have antigens that react with the group F antisera. Table 1 shows results of testing the susceptibility of 1,132 streptococci to commercial bacitracin disks. Results show that 99.5% of the group A streptococci were susceptible to this bacitracin. Among the group B streptococci, 6.0% were susceptible, and only 7.5% of the beta-hemolytic streptococci non-group A, B, or D were susceptible to bacitracin. None of the enterococcal and only 4% of the non-enterococcal group D streptococci were susceptible to commercial bacitracin. Only about 8% of the viridans streptococci were susceptible to commercial bacitracin. Table 3 also shows the tolerance to 6.5% NaCl broth by 3,143 streptococci. Results show that 1.9% of the group A streptococci and nearly 80% of group B streptococci grew in 6.5% NaCl broth; 15 .4% of the beta-hemolytic streptococci non-groups A, B, or D grew in 6.5% NaCl broth. Among these streptococci, 25% of the group C's and 17% of the group G's tolerated 6.5% NaCl broth. Nearly all enterococcal group D strains (99.6%) tolerated 6.5% NaCl broth, whereas 2.2% of the non-enterococcal group D streptococci tolerated the salt broth. Of the 4.7% of the viridans streptococci that were tolerant to 6.5% NaCl broth, none gave positive BEM reactions. The largest percentage of strains among the viridans group that were salt tolerant were unidentified. Fifteen of 68 strains (22%) were salt tolerant. None of these strains could be speciated by physiological tests, and only 30 of 68 strains were from human sources. Table 3 shows the tolerance of 3,143 streptococci to SF broth. Nearly all enterococcal group D streptococci (98%) tolerated SF broth. Forty percent of the non-enterococcal group D streptococci and 13.1% of the viridans tolerated SF broth. These latter two figures are much too high to make SF broth a useful indicator of enterococci. No one species of viridans streptococci was particularly more tolerant than any other to SF broth. Table 4 shows the presumptive test results of 770 streptococci isolated from a series of specimens from mothers and babies during a study to determine the colonization rates of group B streptococci. The results show that all the group A streptococci were correctly identified. All but one of the group B streptococci were correctly identified. Five group G streptococci did not hydrolyze hippurate or blacken BEM, but all of them were susceptible to bacitracin and were, therefore, erroneously identified as presumptive group A streptococci. All five group G strains were isolates from one mother and her baby, so it is likely that all of the isolates were of the same strain. One group C strain was correctly identified as a beta-hemolytic streptococci, non-group A, B, or D. All group D streptococci were correctly identified on the basis of positive BEM reactions. All group D strains in this study were identified as enterococci on the basis of tolerance to salt. Table 5 shows the presumptive test reactions of some bacteria that can be commonly confused with some species of streptococci. S. (diplococcus) pneumoniae were often (48%) susceptible to bacitracin. None of the 17 strains hydrolyzed hippurate, blackened BEM, grew in 6.5% NaCl broth, or tolerated SF broth.
All six of the Aerococcus viridans strains were sensitive to bacitracin, hydrolyzed hippurate, and tolerated 6.5% NaCl and SF broths. Half of the strains blackened BEM. All 27 of the S. salivarius (13) strains were susceptible to bacitracin, but failed to hydrolyze hippurate, serological reaction between the extracted antigen and specific grouping antiserum. The CDC recommends the serological grouping procedure as the method of choice for identifying the streptococci. However, we realize that this method of growing and extracting the organism is time consuming and that the cost of obtaining specific potent antisera makes the method unacceptable for some laboratories. For these laboratories we recommend an alternative method of identifying the pathogenic streptococci which is based on determination of (i) hemolytic activity, (ii) bacitracin susceptibility, (iii) hydrolysis of sodium hippurate, (iv) hydrolysis of esculin in the presence of 40% bile, and (v) tolerance to 6.5% NaCl broth.
The clinical diagnosis of the patient's illness as well as the source of the culture are helpful information in identifying the streptococci. For example, if the specimen is from the cerebrospinal fluid or blood of a neonate (neonatal sepsis or meningitis), the bacteriologist should suspect group B streptococci (as well as Escherichia coli and Listeria monocytogenes). If the specimen is a throat or skin culture (pharyngitis or impetigo), the bacteriologist might well expect to find group A streptococci. Urine specimens may contain group D streptococci. The bacteriologist may find the determination of hemolysis and bacitracin susceptibility are sufficient procedures for investigating throat and skin specimens. The complete procedures listed in Table  6 are not necessary if the physician is interested in only group A or non-group A streptococci from the throat and skin.
Hemolysis. plates should incubate streaked plates under reduced oxygen tension to detect oxygen-labile streptolysin 0 as well as the oxygen-insensitive streptolysin S. Streptococci that produce very little or no streptolysin S appear as "poor surface hemolyzers" or nonhemolytic when incubated under aerobic conditions. The method of stabbing the blood agar plate described by the American Heart Association (22) is not as acceptable as the pour-plate method of determining hemolysis, but it can be used when it is impossible to make pour plates or to incubate anaerobically. Bacitracin. Maxted (15) noted that some alpha-hemolytic streptococci were susceptible to bacitracin. We found about 8% of the viridans strains susceptible. This finding indicates that correct determination of hemolysis is necessary when bacitracin is being used to presumptively identify group A streptococci. It is especially important for throat swabs where alpha-and nonhemolytic streptococci abound.
Our data indicate that more than 99% of the group A streptococci are susceptible to bacitracin and are correctly identified if the test is performed properly. A heavy inoculum of a pure isolate, as suggested by Maxted, is advisable. Minimum zones of inhibition are not required for presumptive group A identification. Any zone of inhibition is considered positive, and no zone is considered negative. Reports of zone size requirements are in the literature (8, 17) , and the technical bulletin of one manufacturer implies that a zone of a certain size is necessary for presumptive identification of group A streptococci. The originator of the test (15) did not specify that zones should be a certain size. No experimental data are available to show that measurement of zones of inhibition is necessary for the differentiation of group A from nongroup A streptococci. By requiring zone sizes of 10 mm or more for presumptive identification of group A streptococci, at least one group of investigators increased the false negative error of the tests by 10% (8) . It is preferable to have more false positive results (an over-diagnosis) rather than false negative results. The users of bacitracin should realize that bacitracin inhibits growth of some strains of beta-hemolytic streptococci other than group A and should report their findings as follows: (i) "presumptive beta-hemolytic group A by bacitracin," or (ii) "beta-hemolytic streptococci non-group A by bacitracin."
Hippurate hydrolysis. The data from this study show that more than 99% of the group B (24) . These strains hydrolyzed hippurate and could be identified as presumptive group B streptococci on the basis of hippurate hydrolysis and the fact that S. acidominimus and S. uberis are rarely found in humans. Unusual strains such as alpha-or nonhemolytic streptococci that hydrolyze hippurate should be sent to state health departments for confirmation and definitive identification.
Bile-esculin test. Bile-esculin medium can be used to differentiate between group D streptococci and non-group D streptococci (10, 11) . Results with 920 strains of group D streptococci show that 99% of the strains will blacken BEM. Non-enterococcal group D streptococci, mainly S. bovis, are found in appreciable numbers of streptococcal infections (9) . Thus, BEM cannot be used to differentiate between enterococcal and non-enterococcal streptococci. An additional test, the 6.5% NaCl broth tolerance test, is necessary to complete the identification of enterococci. All of the viridans streptococci that blackened BEM (5.3%) failed to grow in 6.5% NaCl broth. They were erroneously identified as group D streptococci, not enterococci. A large number of viridans streptococci that blackened BEM were S. mutans. More than half of the S. mutans strains were isolates from dental plaque. The routine clinical laboratory will not receive the high number of S. mutans strains used in this study, and therefore fewer false positive BEM reactions should occur. The antibiotic therapy regimens for enterococcal and non-enterococcal infections are generally dissimilar, so some physicians want a definitive answer as to whether or not the infecting agent is an enterococcus. To ascertain this, the laboratorian must determine salt tolerance of BEMpositive strains. BEM-positive streptococci that are salt tolerant are enterococci; BEM-positive streptococci that fail to grow in 6.5% NaCl broth are group D streptococci, but not enterococci. NaCI tolerance. The alpha-hemolytic streptococci that are BEM negative and fail to grow in 6.5% NaCl broth are members of the viridans streptococci. The species S. mitis, S. MG, S. sanguis, S. salivarius, and S. mutans can be differentiated by additional physiological reactions; however, because they do not differ in susceptibility to antibiotics, clinical microbiologists do not need to speciate them. Alphahemolytic streptococci which are BEM and salt tolerance negative can be reported as viridans streptococci or alpha-hemolytic streptococci, not enterococci, not further identified.
The high percentage of group B streptococci that grow in media containing 6.5% NaCl will not interfere with the presumptive identification procedures. All group B streptococci are bile-esculin negative, and the majority hydrolyze hippurate. This combination of reactions is unique to the beta-hemolytic groups B streptococci.
Salt-tolerant group A streptococci occur occasionally. A strain that is salt tolerance positive and that is not a presumptive group B or presumptive group D streptococcus should be tested for purity by streaking the growth from the salt tolerance test medium onto a blood agar plate and comparing the morphology of this organism with that of the original strain. If the morphology differs, a Gram stain and a catalase test should be performed.
SF broth. We have previously reported (11) that SF broth could be used to differentiate the BEM-positive enterococci from the BEM-positive non-enterococci. The results of our 6-year study show that 40% of the non-enterococcal group D streptococci grew in SF broth, and 13% of the viridans streptococci grew in SF broth, thus making this medium a poor indicator of group D streptococci and an even less successful indicator of enterococci. Braunstein et al. (4) reported some strains of group B streptococci that grew in SF broth, and in a recent study (10) , we have found a lot-to-lot variation in SF broth. The variable reactions of the streptococci in a single lot of SF broth and the lot-to-lot variation in the media make the medium useless as a reliable indicator of either enterococci or group D streptococci.
The reactions of bacteria other than streptococci in these presumptive tests point out some of the pitfalls of presumptive test identification. The microbiologist must be certain that he is testing streptococci when he uses the tests listed in 
